TE
Tema ETFs Portfolio holdings
AUM
$377M
This Quarter Return
-2.81%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$335M
AUM Growth
+$335M
(+39%)
Cap. Flow
+$106M
Cap. Flow
% of AUM
31.69%
Top 10 Holdings %
Top 10 Hldgs %
28.51%
Holding
174
New
26
Increased
81
Reduced
34
Closed
27
Top Buys
| 1 |
Terex
TEX
|
$5.48M |
| 2 |
Herc Holdings
HRI
|
$4.98M |
| 3 |
Bristol-Myers Squibb
BMY
|
$4.58M |
| 4 |
Timken Company
TKR
|
$4.49M |
| 5 |
Eli Lilly
LLY
|
$4.13M |
Top Sells
| 1 |
Primoris Services
PRIM
|
$7.13M |
| 2 |
Fluor
FLR
|
$5.32M |
| 3 |
Federal Signal
FSS
|
$5.11M |
| 4 |
Alnylam Pharmaceuticals
ALNY
|
$2.66M |
| 5 |
Ascendis Pharma
ASND
|
$2.02M |
Sector Composition
| 1 | Industrials | 43.38% |
| 2 | Healthcare | 33.02% |
| 3 | Utilities | 7.31% |
| 4 | Technology | 5.91% |
| 5 | Financials | 4.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
KLA
KLAC
$115B
| $1.43M | 0.43% | 2,102 +1,235 | +142% | +$840K |
|
77
Performance Food Group
PFGC
$15.9B
| $1.31M | 0.39% | +16,706 | New | +$1.31M |
|
78
Cytokinetics
CYTK
$4.23B
| $1.31M | 0.39% | 32,588 -14,795 | -31% | -$595K |
|
79
Lowe's Companies
LOW
$145B
| $1.24M | 0.37% | 5,335 +3,702 | +227% | +$863K |
|
80
Janux Therapeutics
JANX
$1.37B
| $1.24M | 0.37% | 45,937 +40,714 | +780% | +$1.1M |
|
81
Danaher
DHR
$147B
| $1.22M | 0.37% | 5,964 -905 | -13% | -$186K |
|
82
BWX Technologies
BWXT
$14.8B
| $1.2M | 0.36% | 12,186 +8,938 | +275% | +$882K |
|
83
Edwards Lifesciences
EW
$47.8B
| $1.2M | 0.36% | 16,543 -5,092 | -24% | -$369K |
|
84
Canadian Pacific Kansas City
CP
$69.9B
| $1.19M | 0.36% | 16,981 +10,070 | +146% | +$707K |
|
85
Deere & Co
DE
$129B
| $1.13M | 0.34% | 2,397 +1,610 | +205% | +$756K |
|
86
Teradyne
TER
$18.8B
| $1.12M | 0.34% | 13,611 +8,075 | +146% | +$667K |
|
87
Lam Research
LRCX
$127B
| $1.12M | 0.33% | 15,384 +9,120 | +146% | +$663K |
|
88
Insulet
PODD
$23.9B
| $1.09M | 0.32% | 4,134 -1,251 | -23% | -$329K |
|
89
McKesson
MCK
$85.4B
| $1.06M | 0.32% | +1,574 | New | +$1.06M |
|
90
DexCom
DXCM
$29.5B
| $1.04M | 0.31% | 15,271 -13,372 | -47% | -$913K |
|
91
Waters Corp
WAT
$18B
| $1.04M | 0.31% | 2,816 +1,433 | +104% | +$528K |
|
|
92
Ascendis Pharma
ASND
$11.8B
| $952K | 0.28% | 6,106 -12,934 | -68% | -$2.02M |
|
93
Analog Devices
ADI
$124B
| $941K | 0.28% | 4,664 +2,755 | +144% | +$556K |
|
94
IDEAYA Biosciences
IDYA
$2.15B
| $921K | 0.28% | 56,204 +40,138 | +250% | +$657K |
|
95
Canadian National Railway
CNI
$60.4B
| $877K | 0.26% | 8,994 +5,320 | +145% | +$518K |
|
96
Donaldson
DCI
$9.28B
| $795K | 0.24% | 11,848 +7,030 | +146% | +$471K |
|
97
US Foods
USFD
$17.5B
| $780K | 0.23% | +11,917 | New | +$780K |
|
98
Ionis Pharmaceuticals
IONS
$6.8B
| $759K | 0.23% | 25,141 -31,703 | -56% | -$956K |
|
99
Masimo
MASI
$7.59B
| $757K | 0.23% | 4,543 -5,037 | -53% | -$839K |
|
100
Madrigal Pharmaceuticals
MDGL
$9.76B
| $755K | 0.23% | 2,278 -1,342 | -37% | -$445K |
|